Pharmaceutical ETFs Could Maintain Their Momentum
Pharmaceutical stocks and sector-related exchange traded funds have enjoyed a great summer and the rally may continue to have legs. Over the…
PJP
July Could Be a Volatile Month for Pharma ETFs
Changing political winds and the seasonal period for drugmakers to hike their prices could trigger short-term volatility in pharmaceutical sector-related ETFs. The…
6 Top Healthcare ETFs Rally as Trump Vows End to ‘Global Freeloading’
Healthcare stocks and top healthcare ETFs rallied Friday after President Donald Trump vowed to end to “global freeloading” that has allowed foreign…
Get Lucky With 10 Saint Patrick’s Day ETFs
Well folks, it’s that special time of the year on Saturday: the green revolution, the grand day of Guinness, the celebration of corn…
Direxion Resuscitates Leveraged Pharmaceutical ETF
Direxion has revived one of its previously shuttered leveraged ETF ideas and increased the stakes on its original design. On Wednesday, Direxion…
Biotech, Pharma ETFs Leave Pricing Drama Behind
Biotechnology and pharmaceutical ETFs have rallied in recent weeks as drug pricing concerns wane and investors look to the opportunity of this…
Write A Prescription For This Pharma ETF
Pharmaceuticals stocks and exchange traded funds are performing well this year, but some pharmaceuticals ETFs are lagging the performances turned in by…
How a New SCOTUS Ruling Could Affect Pharma ETFs
The VanEck Vectors Generic Drugs ETF (NasdaqGM: GNRX) traded slightly higher Tuesday after the U.S. Supreme Court issued what some industry observers…
Drug Makers, Pharma ETFs Face a Tough Earnings Season
The healthcare sector has been lackluster this earnings season, and without supporting factors such as price increases or increased mergers and acquisitions…
Look to These Sector ETFs in Case of an Election Day Surprise
Heading toward election day, polling surveys and many market watchers anticipate Democrat Hillary Clinton to win the presidential race. However, Republican Donald…
Finding Pharmaceuticals ETFs With Rebound Potential
Like other healthcare exchange traded funds (ETFs), dedicated pharmaceuticals ETFs are struggling this year. While prescription drug sales, such as cialis professional…
The Best Performing ETFs Since the Financial Downturn
Slow and steady value and conservative sectors are leading market gains RPV was best performing non-leveraged ETF across various Morningstar style categories …
Major Pharma Merger Boosts ETFs
Pharmaceuticals giant Pfizer (NYSE: PFE) is in talks to acquire specialty drugmaker Allergan (NYSE: AGN) in what may be the biggest mergers…
Political Placebo: Pharma Regulation
Rare are the investments that can deliver staggering returns over multiple years or even a decade. The PowerShares Dynamic Pharmaceuticals Portfolio (NYSEArca:…